These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6396291)

  • 1. Enzymic hydrolysis of erythromycin by a strain of Escherichia coli. A new mechanism of resistance.
    Barthélémy P; Autissier D; Gerbaud G; Courvalin P
    J Antibiot (Tokyo); 1984 Dec; 37(12):1692-6. PubMed ID: 6396291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the nucleotide sequence of the ereB gene encoding the erythromycin esterase type II.
    Arthur M; Autissier D; Courvalin P
    Nucleic Acids Res; 1986 Jun; 14(12):4987-99. PubMed ID: 3523438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid-mediated high-level resistance to erythromycin in Escherichia coli.
    Andremont A; Gerbaud G; Courvalin P
    Antimicrob Agents Chemother; 1986 Mar; 29(3):515-8. PubMed ID: 3521489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythromycin-resistant mutant of Escherichia coli with altered ribosomal protein component.
    Tanaka K; Teraoka H; Tamaki M; Otaka E; Osawa S
    Science; 1968 Nov; 162(3853):576-8. PubMed ID: 4886608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of two different mechanisms to erythromycin resistance in Escherichia coli.
    Arthur M; Courvalin P
    Antimicrob Agents Chemother; 1986 Nov; 30(5):694-700. PubMed ID: 3541783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of genes conferring high-level resistance to erythromycin by inactivation in enterobacteria.
    Arthur M; Andremont A; Courvalin P
    Ann Inst Pasteur Microbiol (1985); 1986; 137A(2):125-34. PubMed ID: 3322168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear magnetic resonance studies on the mode of action of erythromycin A.
    Gyi JI; Barber J
    Biochem Soc Trans; 1991 Aug; 19(3):313S. PubMed ID: 1783149
    [No Abstract]   [Full Text] [Related]  

  • 8. Properties of ribosomes from erythromycin resistant mutants of Escherichia coli.
    Pardo D; Rosset R
    Mol Gen Genet; 1977 Nov; 156(3):267-71. PubMed ID: 340907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides.
    Wondrack L; Massa M; Yang BV; Sutcliffe J
    Antimicrob Agents Chemother; 1996 Apr; 40(4):992-8. PubMed ID: 8849266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of a phosphorylated derivative of oleandomycin, obtained by reaction of oleandomycin with an extract of an erythromycin-resistant strain of Escherichia coli.
    O'Hara K; Kanda T; Kono M
    J Antibiot (Tokyo); 1988 Jun; 41(6):823-7. PubMed ID: 3042731
    [No Abstract]   [Full Text] [Related]  

  • 11. Reducing residual antibiotic levels in animal feces using intestinal Escherichia coli with surface-displayed erythromycin esterase.
    Liu M; Feng P; Kakade A; Yang L; Chen G; Yan X; Ni H; Liu P; Kulshreshtha S; Abomohra AE; Li X
    J Hazard Mater; 2020 Apr; 388():122032. PubMed ID: 31955024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low affinity for chloramphenicol of erythromycin resistant Escherichia coli ribosomes having an altered protein component.
    Tanaka K; Tamaki M; Takata R; Osawa S
    Biochem Biophys Res Commun; 1972 Mar; 46(6):1979-83. PubMed ID: 4553152
    [No Abstract]   [Full Text] [Related]  

  • 13. Ribosomal protein gene sequence changes in erythromycin-resistant mutants of Escherichia coli.
    Chittum HS; Champney WS
    J Bacteriol; 1994 Oct; 176(20):6192-8. PubMed ID: 7928988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoside cleavage reactions on erythromycin A. Preparation of erythronolide A.
    LeMahieu RA; Carson M; Kierstead RW; Fern LM; Grunberg E
    J Med Chem; 1974 Sep; 17(9):953-6. PubMed ID: 4213128
    [No Abstract]   [Full Text] [Related]  

  • 15. Macrolide esterase-producing Escherichia coli clinically isolated in Japan.
    Nakamura A; Nakazawa K; Miyakozawa I; Mizukoshi S; Tsurubuchi K; Nakagawa M; O'Hara K; Sawai T
    J Antibiot (Tokyo); 2000 May; 53(5):516-24. PubMed ID: 10908116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmid-mediated susceptibility to intestinal microbial antagonisms in Escherichia coli.
    Andremont A; Gerbaud G; Tancrède C; Courvalin P
    Infect Immun; 1985 Sep; 49(3):751-5. PubMed ID: 3897062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythromycin binding is reduced in ribosomes with conformational alterations in the 23 S rRNA peptidyl transferase loop.
    Douthwaite S; Aagaard C
    J Mol Biol; 1993 Aug; 232(3):725-31. PubMed ID: 7689111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of macrolide 2'-phosphotransferase from a strain of Escherichia coli that is highly resistant to erythromycin.
    O'Hara K; Kanda T; Ohmiya K; Ebisu T; Kono M
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1354-7. PubMed ID: 2478074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic studies of erythromycin resistant mutants of Escherichia coli.
    Pardo D; Rosset R
    Mol Gen Genet; 1974; 135(3):257-68. PubMed ID: 4617168
    [No Abstract]   [Full Text] [Related]  

  • 20. Microbial glycosylation of erythromycin A.
    Kuo MS; Chirby DG; Argoudelis AD; Cialdella JI; Coats JH; Marshall VP
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2089-91. PubMed ID: 2619274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.